Lutathera (Lutetium-177 DOTATATE)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutathera (Lutetium-177 DOTATATE), covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment [Phase 2]